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Methods and Materials
I used the Abbott Bichromatic Analyzer (ABA-100), and the conditions for analysis are shown in Table 1 .
Filter Set Construction A 650/600 nm filter wheel combination was constructed from filter wheel components obtained from Abbott Laboratories, Diagnostics Division, South Pasadena, Calif. 91030. I chose a primary wavelength of 650 nm and a secondary wavelength of 600 nm in order to cause the apparent reaction direction to be negative-going and thereby allow the instrument logic to indicate termination of zero-order kinetics by shift to a red printer ribbon1 when the apparent absorbance passed a pre-set value. The filter wheel was balanced by adding neutral density filters to the primary filters to allow a zero setting of 2500 with a scaling factor of 0500.
Reagents p-Nit rophenyl phosphate: "A-Gent Alkaline Phosphatase Test" (Abbott Laboratories) was used as suggested by the manufacturer. Table 2 itemizes the components of the product.
Thymol blue monophosphate:
"Deltatest#{174} ALP, Alkaline Phosphatase Reagent" (cat. No. 831; Princeton Biomedix, Inc., Princeton, N. J. 08540) was prepared as suggested by the manufacturer by diluting equal parts of diethanolamine buffer and substrate. The components of the mixture are also indicated in Table 2 .
Standards
Recrystallized p-nitrophenyl phosphate was used to verify the filter factor (millimolar absorptivity a415-a450) of the 'The ABA-100 is designed so that when the apparent Ad of the reaction becomes negative, the printer ribbon shifts to red. The zero adjustment is set such that the apparent Ad becomes negative just before zero-order kinetics end. A solution of crystalline thymol blue was used to obtain the filter factor for the 650/600 nm filter set I used in this assay. The millimolar absorptivity of thymol blue at 600 nm is 35.1 liters mmol' cm.
The millimolar absorptivity (a&jo-asso)
for the filter set I used in this study was determined to be 22.44 liters mmolt cm'.
Results
Comparison Studies I assayed aliquots of serum for 144 patients by both the automated kinetic p-nitrophenyl phosphate method and the automated kinetic thymol blue monophosphate method, with the same instrument. Figure 1 shows the results. The correlation between the two sets of results is quite good (r = 0.9949). The slope is 0.425; the fact that it is less than 1.0 indicates that the substrate is not acted on as rapidly as is p-nitrophenyl and placenta obtained at delivery. Purity and identity of phosphatase activity in each concentrate were assessed by the electrophoretic method of Fritsche and Adams-Park (7). The relative activity of isoenzymes (expressed as a percentage of the activity obtained when p-nitrophenyl phosphate was used as a substrate) varies with the tissue of origin: intestine, 53.9%; liver, 42.6%; bone, 36.4%; and placenta, 24.4%. The relative response of the substrate with alkaline phosphatase of placental origin is markedly less than with the isoenzymes from the other tissues.
Because of the relative lack of sensitivity of thymol blue monophosphate to placental isoenzyme, I decided to measure alkaline phosphatase activity in the sera of women in their thirty-second and thirty-third weeks of pregnancy. Occasionally, the alkaline phosphatase activity in the serum of a pregnant woman will show a borderline increase when p-nitrophenyl phosphate is used as the substrate. The advantages of having a stable substrate that may be prepared in advance and stored for long periods are that reagent preparation time is minimized and reagent wastage virtually eliminated. The reactivity of the various isoenzymes of alkaline phosphatase toward this substrate differs from that of p-nitrophenyl phosphate, the order of reactivity being intestinal> liver> bone > placental. Because of the low reactivity toward the placental isoenzyme, the substrate may be useful in detecting liver disease in pregnant women with more sensitivity than when p-nitrophenyl phosphate is used.
